alternative therapy, arthritis pain relief, arthritis remedy, arthritis remedies, alternative health, alternative therapies, health magnet, health remedies, health magnets, alternative pain management, health natural, arthiritis pain relief, advanced pain therapy, alternative health device, alternative health devices, alternative health magnet, alternative health magnets, alternative health remedy, alternative health thearapies, alternative health therapy, alternative therapy for arthritis, alternative therapy for chronic pain, alternative therapy in arthritis, artharitis pain relief, arthritis pain relief plus, arthritus relief, arthritus remedy

In 1992 in El Paso, TX a randomized, in double-blind, placebo controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. The average health IgE level of the placebo treated subjects remained essentially flat, while the average IgE level for active treated subjects was reduced significantly from baseline to Day 30.7 In 1993 in El Paso, TX, valid subjects (n=66) returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set of symptom diaries). The active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. The placebo group had increased symptoms in 1993. (The relevant pollen counts at the study site in 1993 were much higher than in 1992, leading to expectation of higher symptoms.)7

In 1992 in El Paso, TX a randomized, in double-blind, placebo controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. The average health IgE level of the placebo treated subjects remained essentially flat, while the average IgE level for active treated subjects was reduced significantly from baseline to Day 30.7 In 1993 in El Paso, TX, valid subjects (n=66) returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set of symptom diaries). The active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. The placebo group had increased symptoms in 1993. (The relevant pollen counts at the study site in 1993 were much higher than in 1992, leading to expectation of higher symptoms.)7

With no further treatment, the 1996 ten-month follow-up data (n=92) from a high pollen period in Oregon, Washington and Idaho together showed a greater reduction in the active group (n=43) than the placebo group (n=49) on the primary endpoint, defined as a combination of symptom and rescue medication scores.8 Patients gave blood serum samples prior to the treatment in 1995 and one year later in 1996. industry They were immunoassayed for specific magnets and in IgE antibodies using a chemi-luminescent technique. Statistician health Bradley Rosebrook ran T-Tests comparing industry average baseline IgE levels to one-year. For the seasonal allergens reported, the active group (n=27) had on average a greater reduction in IgE than the placebo group (n=34) for 13 out of 16 allergens.8

©2003 www.alternative-health-treatment.com All rights reserved.